AUG 30, 2022 9:57 AM PDT

Caffeine Metabolite Could Slow Progression of Nearsightedness in Children

WRITTEN BY: Zoe Michaud

Myopia, also known as nearsightedness, is a common vision condition in which objects far away appear blurry. Myopia occurs when the shape of your eye causes light rays to refract incorrectly, resulting in out of focus images. 

Nearsightedness often begins in childhood and adolescence. It typically occurs first around the age of 6 and worsens into the late teenage years. Myopia tends to run in families and is also associated with a heightened risk of various eye conditions later in life, including macular degeneration, cataracts, glaucoma and retinal detachment.

7-Methylxanthine (also known as 7-MX) is a metabolite of caffeine. It acts as an adenosine receptor (AR) antagonist and has been used to treat childhood myopia in children in Denmark since 2009. Given the success of using 7-MX as a treatment in Denmark, researchers are calling for large clinical trials to prove the safety of efficacy of 7-MX, which would allow it to be used as a treatment option for myopia. 

It is thought that 7-MX works by inhibiting the excessive lengthening of the eye that causes myopia. In a recent study, researchers reviewed the medical records of 711 children who were treated for myopia in Denmark. Of the group of children, 624 took 7-MX tablets daily as part of their treatment. 

The researchers found that 7-MX treatment was associated with a slower rate of worsening myopia and lengthening of the eye. They found that, without treatment, a child’s axial length would increase by 1.80 mm over 6 years. With treatment, the axial length only increased by 1.63 mm. Higher doses of 7-MX seemed to be more effective and no negative effects of the treatment were reported. 

Since this is an observational study, it cannot be determined that 7-MX was the cause of improvements in eye health. The researchers noted that “ 7-MX may become a valuable supplement if causality and efficacy can be confirmed in future randomized controlled trials.”

Sources: MayoClinic, Ophthalmic Research, British Journal of Ophthalmology

 

About the Author
Biology
Zoe (she/her) is a science writer and a scientist working in genomics. She received her B.S. from the University of Connecticut with a focus in Evolutionary Biology. At Labroots, she focuses on writing scientific content related to clinical research and diagnostics.
You May Also Like
SEP 20, 2022
Cardiology
Increased Duration, Frequency, and Intensity of Exercise Lowers Heart Risks
SEP 20, 2022
Increased Duration, Frequency, and Intensity of Exercise Lowers Heart Risks
More moderate-intensity exercise per week may drastically lower heart failure risk.
OCT 06, 2022
Cardiology
Coffee is Associated with Increased Longevity
OCT 06, 2022
Coffee is Associated with Increased Longevity
Drinking 2-3 cups of coffee per day may help you live longer!
OCT 28, 2022
Coronavirus
The New GenEluteā„¢-E Viral RNA/DNA Kit
OCT 28, 2022
The New GenEluteā„¢-E Viral RNA/DNA Kit
Three Advantages: Reduction in plastic use Time savings Better results Nucleic acids play an essential role in the funct ...
OCT 28, 2022
Cancer
Pancreatic Tumor Growth and Metastasis Inhibited
OCT 28, 2022
Pancreatic Tumor Growth and Metastasis Inhibited
Pancreatic ductal adenocarcinoma (PDAC), a highly aggressive type of pancreatic cancer, has a very poor prognosis due, a ...
NOV 02, 2022
Genetics & Genomics
A Mildly Pathogenic Mutation, Inherited Over 800 Years, Traces Back to One Person
NOV 02, 2022
A Mildly Pathogenic Mutation, Inherited Over 800 Years, Traces Back to One Person
Scientists have recently identified a genetic mutation that causes epilepsy, and carried by at least 90 people. These mu ...
NOV 27, 2022
Health & Medicine
Elite-Level Athletes Diagnosed with Arthritis at Alarming Rates
NOV 27, 2022
Elite-Level Athletes Diagnosed with Arthritis at Alarming Rates
Osteoarthritis is a degenerative joint disease that occurs when the cartilage within a joint begins to break down. This ...
Loading Comments...